SEPN
Septerna, Inc.
$36.40
+0.57 (+1.59%)
At close · Jul 8
Market Cap
$1.64B
Shares
45,075,533
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$36.40
Open$35.37
Day$34.75–37.26
52W$10.62–37.99
Avg vol 30d467K
Short int2.7M · 5.9% float · 7.8d
Short vol35%
Last earningsMay 11, 2026
DataOct 2024–Jul 2026
Filing10-Q · May 11
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bearish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+40%
above
Price vs 50-day avg
+21%
above
RSI (14)
60
neutral
MACD trend
Negative
52-week position
94%
near high
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+20%
trailing
6-month return
+38%
trailing
YTD return
+31%
this year
Relative strength
+30%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $30 › 200d $26 — 50d above 200d
Institutional flow
Distributing
3 of 124 funds reported for Jun 30 · net -22 sh shares
Insider flow
Distributing
Net -$623.7K over 90 days · 100% sells
Short interest
Rising
5.91% of float · ▲ +1.8% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
124 holders — near 1-yr high, broad support
Squeeze score
77
high risk · 0–100
Fundamentals
Revenue growth
+4175%
Y/Y
EPS growth
+85%
Y/Y
Free cash flow
$109.7M
Balance sheet
$120.7M
net cash
Quant / Vol
risk profile
Volatility
65%
annualized · 1-yr
Max drawdown
−25%
past year
ATR
6.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 4 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 11, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+40%
Bullish
Price vs 50-day avg
+21%
Bullish
RSI (14)
60
Neutral
MACD trend
Negative
Bearish
52-week position
94%
Bullish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $30 › 200d $26 — 50d above 200d
Institutional flow
Distributing
3 of 124 funds reported for Jun 30 · net -22 sh shares
Insider flow
Distributing
Net -$623.7K over 90 days · 100% sells
Short interest
Rising
5.91% of float · ▲ +1.8% MoM · 7.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
124 holders — near 1-yr high, broad support
Price context
position in its 52-week range
52-wk low $11
Now $36 · 94%
52-wk high $38
vs 200-day avg +40%
vs 50-day avg +21%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SEPN
this stock
Septerna, Inc.
|
$1.64B | +30.6% | +4174.5% | — | 5.9% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$132.55B | +15.2% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.49B | +9.4% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SEPN | +8.7% | +19.7% | +38.0% | +8.7% | +30.6% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +7.8% | +18.3% | +30.4% | +8.6% | +20.9% |